Global Hepatitis B Vaccines Market Research Report 2023(Status and Outlook)

Global Hepatitis B Vaccines Market Research Report 2023(Status and Outlook)



Report Overview

Hepatitis B vaccine is a vaccine that prevents hepatitis B.

In the last several years, Global market of Hepatitis B vaccine developed smoothly, with an average growth rate of -0.32%.

The classification of Hepatitis B vaccine includes Yeast Derived, CHO Derived, and the sales proportion of Yeast Derived in 2019 is about 97%. Hepatitis B vaccine is widely used for Children and Adult. About 84% of Hepatitis B vaccine is used for Children.

Asia-Pacific is the largest consumption place, with a consumption market share nearly 50% in 2019. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of nearly 30%.

Market competition is intense. GSK, NCPC, Merck, Bio Kangtai, Dynavax, Hissen, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.

The Global Hepatitis B Vaccines Market Size was estimated at USD 1004.90 million in 2022 and is projected to reach USD 1138.56 million by 2029, exhibiting a CAGR of 1.80% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Hepatitis B Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Hepatitis B Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Hepatitis B Vaccines market in any manner.

Global Hepatitis B Vaccines Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

GSK

NCPC

Merck

Bio Kangtai

Dynavax

Hissen

KM Biologics

LG Life Sciences

Serum Institute

Market Segmentation (by Type)

Yeast Derived

CHO Derived

Market Segmentation (by Application)

BFSI

IT & Telecom

Government & Public Sector

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Hepatitis B Vaccines Market

Overview of the regional outlook of the Hepatitis B Vaccines Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Hepatitis B Vaccines
1.2 Key Market Segments
1.2.1 Hepatitis B Vaccines Segment by Type
1.2.2 Hepatitis B Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Hepatitis B Vaccines Market Overview
2.1 Global Market Overview
2.1.1 Global Hepatitis B Vaccines Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Hepatitis B Vaccines Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Hepatitis B Vaccines Market Competitive Landscape
3.1 Global Hepatitis B Vaccines Sales by Manufacturers (2018-2023)
3.2 Global Hepatitis B Vaccines Revenue Market Share by Manufacturers (2018-2023)
3.3 Hepatitis B Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Hepatitis B Vaccines Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Hepatitis B Vaccines Sales Sites, Area Served, Product Type
3.6 Hepatitis B Vaccines Market Competitive Situation and Trends
3.6.1 Hepatitis B Vaccines Market Concentration Rate
3.6.2 Global 5 and 10 Largest Hepatitis B Vaccines Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Hepatitis B Vaccines Industry Chain Analysis
4.1 Hepatitis B Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Hepatitis B Vaccines Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Hepatitis B Vaccines Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hepatitis B Vaccines Sales Market Share by Type (2018-2023)
6.3 Global Hepatitis B Vaccines Market Size Market Share by Type (2018-2023)
6.4 Global Hepatitis B Vaccines Price by Type (2018-2023)
7 Hepatitis B Vaccines Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hepatitis B Vaccines Market Sales by Application (2018-2023)
7.3 Global Hepatitis B Vaccines Market Size (M USD) by Application (2018-2023)
7.4 Global Hepatitis B Vaccines Sales Growth Rate by Application (2018-2023)
8 Hepatitis B Vaccines Market Segmentation by Region
8.1 Global Hepatitis B Vaccines Sales by Region
8.1.1 Global Hepatitis B Vaccines Sales by Region
8.1.2 Global Hepatitis B Vaccines Sales Market Share by Region
8.2 North America
8.2.1 North America Hepatitis B Vaccines Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Hepatitis B Vaccines Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Hepatitis B Vaccines Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Hepatitis B Vaccines Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Hepatitis B Vaccines Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 GSK
9.1.1 GSK Hepatitis B Vaccines Basic Information
9.1.2 GSK Hepatitis B Vaccines Product Overview
9.1.3 GSK Hepatitis B Vaccines Product Market Performance
9.1.4 GSK Business Overview
9.1.5 GSK Hepatitis B Vaccines SWOT Analysis
9.1.6 GSK Recent Developments
9.2 NCPC
9.2.1 NCPC Hepatitis B Vaccines Basic Information
9.2.2 NCPC Hepatitis B Vaccines Product Overview
9.2.3 NCPC Hepatitis B Vaccines Product Market Performance
9.2.4 NCPC Business Overview
9.2.5 NCPC Hepatitis B Vaccines SWOT Analysis
9.2.6 NCPC Recent Developments
9.3 Merck
9.3.1 Merck Hepatitis B Vaccines Basic Information
9.3.2 Merck Hepatitis B Vaccines Product Overview
9.3.3 Merck Hepatitis B Vaccines Product Market Performance
9.3.4 Merck Business Overview
9.3.5 Merck Hepatitis B Vaccines SWOT Analysis
9.3.6 Merck Recent Developments
9.4 Bio Kangtai
9.4.1 Bio Kangtai Hepatitis B Vaccines Basic Information
9.4.2 Bio Kangtai Hepatitis B Vaccines Product Overview
9.4.3 Bio Kangtai Hepatitis B Vaccines Product Market Performance
9.4.4 Bio Kangtai Business Overview
9.4.5 Bio Kangtai Hepatitis B Vaccines SWOT Analysis
9.4.6 Bio Kangtai Recent Developments
9.5 Dynavax
9.5.1 Dynavax Hepatitis B Vaccines Basic Information
9.5.2 Dynavax Hepatitis B Vaccines Product Overview
9.5.3 Dynavax Hepatitis B Vaccines Product Market Performance
9.5.4 Dynavax Business Overview
9.5.5 Dynavax Hepatitis B Vaccines SWOT Analysis
9.5.6 Dynavax Recent Developments
9.6 Hissen
9.6.1 Hissen Hepatitis B Vaccines Basic Information
9.6.2 Hissen Hepatitis B Vaccines Product Overview
9.6.3 Hissen Hepatitis B Vaccines Product Market Performance
9.6.4 Hissen Business Overview
9.6.5 Hissen Recent Developments
9.7 KM Biologics
9.7.1 KM Biologics Hepatitis B Vaccines Basic Information
9.7.2 KM Biologics Hepatitis B Vaccines Product Overview
9.7.3 KM Biologics Hepatitis B Vaccines Product Market Performance
9.7.4 KM Biologics Business Overview
9.7.5 KM Biologics Recent Developments
9.8 LG Life Sciences
9.8.1 LG Life Sciences Hepatitis B Vaccines Basic Information
9.8.2 LG Life Sciences Hepatitis B Vaccines Product Overview
9.8.3 LG Life Sciences Hepatitis B Vaccines Product Market Performance
9.8.4 LG Life Sciences Business Overview
9.8.5 LG Life Sciences Recent Developments
9.9 Serum Institute
9.9.1 Serum Institute Hepatitis B Vaccines Basic Information
9.9.2 Serum Institute Hepatitis B Vaccines Product Overview
9.9.3 Serum Institute Hepatitis B Vaccines Product Market Performance
9.9.4 Serum Institute Business Overview
9.9.5 Serum Institute Recent Developments
10 Hepatitis B Vaccines Market Forecast by Region
10.1 Global Hepatitis B Vaccines Market Size Forecast
10.2 Global Hepatitis B Vaccines Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Hepatitis B Vaccines Market Size Forecast by Country
10.2.3 Asia Pacific Hepatitis B Vaccines Market Size Forecast by Region
10.2.4 South America Hepatitis B Vaccines Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Hepatitis B Vaccines by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Hepatitis B Vaccines Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Hepatitis B Vaccines by Type (2024-2029)
11.1.2 Global Hepatitis B Vaccines Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Hepatitis B Vaccines by Type (2024-2029)
11.2 Global Hepatitis B Vaccines Market Forecast by Application (2024-2029)
11.2.1 Global Hepatitis B Vaccines Sales (K MT) Forecast by Application
11.2.2 Global Hepatitis B Vaccines Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings